High Cost of Procedures and Limited Reimbursement: A Major Constraint on Penetration in the Neuromodulation Devices Market
A primary structural barrier significantly limiting the patient uptake and market penetration of implantable technologies in the Neuromodulation Devices Market is the substantially high total cost of the procedure and the inconsistency of reimbursement coverage across many geographies. The total procedural expense is massive, encompassing the high price of the implantable device itself (e.g.,...
0 Yorumlar 0 hisse senetleri 642 Views 0 önizleme